INVESTMENT (Details Narrative) - USD ($) |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
ILiAD Biotechnologies, LLC [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Aggregrate investment | $ 7,000,000 | |
Book value of the investment | $ 6,054,000 | |
Iliad [Member] | Class C Units [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Ownership percentage not fully diluted | 6.70% | |
Iliad [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Aggregrate investment | $ 7,000,000 | |
Equity investment net loss | $ 628,000 | $ 674,000 |
Iliad [Member] | Class C Units [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Ownership percentage fully diluted | 5.40% |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|